[Adjuvant treatment of prostatic carcinoma after primary therapy. The "Early Prostate Cancer" Program].
Mansueto
Giovanni
G
U.B. Oncologia Medica, Ospedale Regionale Valle D'Aosta.
Longo
Flavia
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000813:Anilides / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D002369:Castration; D017024:Chemotherapy, Adjuvant; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009570:Nitriles; D018579:Patient Selection; D010919:Placebos; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D014105:Tosyl Compounds
D000726:Androgen Antagonists; D000813:Anilides; D000970:Antineoplastic Agents; D009570:Nitriles; D010919:Placebos; D014105:Tosyl Compounds; C053541:bicalutamide; D017430:Prostate-Specific Antigen
Trattamento adiuvante del carcinoma prostatico dopo terapia primaria. Il Programma "Early Prostate Cancer".